Thus far, our findings indicated that upon treatment with CIRT+HCQ, cancer cells expressed higher levels of MHC‐I, which in turn may have activated and expanded CD8+ T cells, eventually leading to the dampening of tumor growth. Here, CD8A is linked to cancer.